Artificial sweeteners induce glucose intolerance by altering the gut microbiota
AbstractNon-caloric artificial sweeteners (NAS) are among the most widely used food additives worldwide, regularly consumed by lean and obese individuals alike. NAS consumption is considered safe and beneficial owing to their low caloric content, yet supporting scientific data remain sparse and controversial. Here we demonstrate that consumption of commonly used NAS formulations drives the development of glucose intolerance through induction of compositional and functional alterations to the intestinal microbiota. These NAS-mediated deleterious metabolic effects are abrogated by antibiotic treatment, and are fully transferrable to germ-free mice upon faecal transplantation of microbiota configurations from NAS-consuming mice, or of microbiota anaerobically incubated in the presence of NAS. We identify NAS-altered microbial metabolic pathways that are linked to host susceptibility to metabolic disease, and demonstrate similar NAS-induced dysbiosis and glucose intolerance in healthy human subjects. Collectively, our results link NAS consumption, dysbiosis and metabolic abnormalities, thereby calling for a reassessment of massive NAS usage.
人工甘味料でカロリーは抑えることができるが、血糖値を上げてしまうこともある。
腸内細菌がカギを握っている。
腸内細菌といえばこんな論文も
J Clin Invest. 2014 Aug 1;124(8):3391-406. doi: 10.1172/JCI72517. Epub 2014 Jun 24.
Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity.
AbstractMetabolic disorders, including obesity, diabetes, and cardiovascular disease, are widespread in Westernized nations. Gut microbiota composition is a contributing factor to the susceptibility of an individual to the development of these disorders; therefore, altering a person's microbiota may ameliorate disease. One potential microbiome-altering strategy is the incorporation of modified bacteria that express therapeutic factors into the gut microbiota. For example, N-acylphosphatidylethanolamines (NAPEs) are precursors to the N-acylethanolamide (NAE) family of lipids, which are synthesized in the small intestine in response to feeding and reduce food intake and obesity. Here, we demonstrated that administration of engineered NAPE-expressing E. coli Nissle 1917 bacteria in drinking water for 8 weeks reduced the levels of obesity in mice fed a high-fat diet. Mice that received modified bacteria had dramatically lower food intake, adiposity, insulin resistance, and hepatosteatosis compared with mice receiving standard water or control bacteria. The protective effects conferred by NAPE-expressing bacteria persisted for at least 4 weeks after their removal from the drinking water. Moreover, administration of NAPE-expressing bacteria to TallyHo mice, a polygenic mouse model of obesity, inhibited weight gain. Our results demonstrate that incorporation of appropriately modified bacteria into the gut microbiota has potential as an effective strategy to inhibit the development of metabolic disorders.
肥満を腸内細菌叢をターゲットに治療できそうです。
今年３月、慶応義塾大学病院で潰瘍性大腸炎の患者さんに糞便微生物移植をに行いましたね。
腸内細菌叢をうまくコントロールすることによりに色々な病気に応用できそうです。
米国のガイドラインは人工甘味料について
Based on existing evidence, guidelines jointly published in 2012 by the American Heart Association and the American Diabetes Association noted that artificial sweeteners "when used judiciously…could facilitate reductions in added sugar," and thus influence weight loss.
when used judiciously…
昨日の常識は今日の非常識、今日の非常識が明日の常識。
振り回されることなく自分で決めて納得することです。
アンチエイジング、健康的なダイエットの基本は食事と適度な運動、睡眠です。
サプリだけで健康は維持できません。運動も、やりすぎはダメです。
ダイエット きっかけ 健康的 アンチエイジング
